Clinical trials

Woman having an eye test
#Cell and gene therapy #Clinical trials #Gene therapy #Genetics / genomics #GenSight Biologics #Ophthalmology

Five-year data show gene therapy safe for ND4-LHON

GenSight Biologics has revealed pooled safety data from five clinical studies of lenadogene nolparvovec (Lumevoq), the largest cohort of ND4-LHON (Leber hereditary optic neuropathy) patients studied after gene therapy treatment. The data confirms the good overall safety profile of the product in terms of systemic and… Read More

#News

#Cancer research #Clinical trial design #Clinical trials #Drug discovery #Gene therapy #Oncology

This week in drug discovery (6-10 March)

News round-up for 6-10 March by DDW Digital Content Editor Diana Spencer.  Perhaps most interestingly this week, after previous caution over in vivo gene therapy trials, the FDA has given the go ahead to Intellia Therapeutics to study NTLA-2002 in hereditary angioedema (HAE).  There have been several… Read More

#News

Clinical trial
#Clinical trial design #Clinical trials #Collaboration #Duke Clinical Research Institute #Partnership #Protas

Research organisations partner to transform clinical trials

The Duke Clinical Research Institute (DCRI) and Protas, led by Oxford University clinical trialist Professor Sir Martin Landray, will collaborate to develop new approaches to large randomised clinical trials.  Through the collaboration, the partners hope to enable better evidence-based treatments for common conditions, such as heart and… Read More

#News

Clinical trials
#Breast cancer #Cancer research #Clinical research #Clinical trials #Covid-19 #Oncology

What are the top disease areas for clinical drug trials?

Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, according to a recent report by analytics company Phesi. Here, we take a look at the top four disease areas and some of the key developments in 2022.  1. Breast cancer In April, Biotech ISA… Read More

#Exclusive Content

Female doctor analysing liquid in test tube
#Clinical trial design #Clinical trials #Evoke Galliard #Sponsored content

Overcoming the blocks to successful clinical trials

This article is sponsored by Evoke. Dominic Elliston, Managing Director of Evoke Galliard and Evoke Incisive Health, shares his take on how effective clinical trial communications is the key to expediting the delivery of new and extraordinary treatments. Tell us about yourself, Dominic. My name is Dominic – most people… Read More

#Exclusive Content

#Breast cancer #Cancer research #Clinical trial design #Clinical trials #Drug development #Drug discovery #Oncology #Phase III trial

This week in drug discovery (6-10 February)

News round-up for 6-10 February by DDW Digital Content Editor Diana Spencer.  Clinical drug trials have made the headlines this week, as it was revealed that breast cancer still tops the bill for number of clinical studies and the shortcomings in current methods to ensure representation of patient… Read More

#News

Patient having a mammogram
#Breast cancer #Cancer research #Clinical research #Clinical trials #Oncology #Phase II trial

Breast cancer still top disease area for clinical studies

Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, despite a drop in activity, according to analysis from analytics company Phesi.  The company’s global analysis of all clinical trials conducted in 2022 showed that Covid-19 came second.   Three of… Read More

#Cancer Research #News

#Cancer research #Clinical trials #Healthcare

Improving clinical trials through patient experience

Stitch Health is a London-based start-up, on a mission to improve clinical trials by measuring and surfacing each patient’s experience. DDW’s Megan Thomas caught up with Jonathan Moshinsky, Co-Founder and CEO.  MT: Near the end of 2022, Stitch closed £2.5 million seed funding to create the definitive patient retention platform… Read More

#Business & Investment #Exclusive Content #Start-up Zone

Diversity
#Clinical research #Clinical trial design #Clinical trials #Diversity #Epidemiology #GSK #United States

Study shines a light on representation in clinical research

A diversity study has shown that clinical trials should use real world diseases epidemiology data, rather than US Census Bureau race and ethnicity data, to ensure enrolment reflects the populations affected by different diseases.  GSK’s retrospective study looked at clinical trial demographic data from 495 GSK and… Read More

#Editor's Choice #News

#Clinical trial design #Clinical trials #Contract Research Organisations (CROs) #Decentralised clinical trials

Choosing the right site solution for clinical trials

Listen to this article on the DDW podcast: Independent Medical Writer Leonie Onslow explores the challenges of traditional clinical trial models and how to improve recruitment and retention. Covid-19 and the subsequent strain on health systems and research capabilities has created the opportunity to change the traditional clinical trial model of… Read More

#Exclusive Content

Medicinal cannabis
#Cannabinoid #Clinical trials #Medicinal cannabis #Plant-based

Medicinal cannabis: Why more clinical trials and better access is needed

Listen to this article on the DDW podcast: Michael Sassano, CEO at SOMAÍ Pharmaceuticals looks at what’s needed throughout Europe to help increase access to medicinal cannabis and the current state of pharmaceutical research in this area. The use of medicinal cannabis across much of the world is still in its… Read More

#Exclusive Content

Drug discovery concept petri dish
#AI / data analytics / healthtech / informatics #Biopharma #Business #Clinical trials #Drug discovery #Genetics / genomics #Genomics #Market reporting

What to expect from drug discovery and development in 2023

DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year.   The Market After over two years of the Covid-19 pandemic, 2022 year was somewhat of a return to normal… Read More

#Exclusive Content

#Clinical trial design #Clinical trials #Decentralised clinical trials

What are the opportunities for decentralised clinical trials?

Listen to this article on the DDW podcast: Tom Brazier, Director, Decentralised Clinical Solutions, mdgroup and Stephanie Larimer, Q² Solutions discuss the opportunities for decentralised clinical trials and how common pitfalls can be avoided through communications and streamlined working. Hybrid and decentralised clinical trials (DCTs) are fast becoming the norm, but… Read More

#Exclusive Content

Luchen Li, wearing the sensor suit, and Professor Aldo Faisal.
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Clinical trials #Imperial College London #Movement disorders #Rare disease #Wearable tech

AI and wearable tech could speed up drug development

A multi-disciplinary team of researchers has developed a way to monitor the progression of movement disorders using motion capture technology and AI.   By combining human movement data gathered from wearable tech with a powerful new medical AI technology, the team were able to significantly increase the efficiency… Read More

#News

#Cancer research #Clinical trials #Drug development #Drug discovery #Phase I trial #Phase II trial #Phase III trial

DDW Highlights podcast: 23 January 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Clinical trials have led our news section this week, with positive results… Read More

#News

#Clinical trials #Drug development #EU #FDA #Regulatory

Regulatory affairs in 2023: Key trends and changes  

Dr Julie Warner is Vice President of Regulatory Affairs at global drug development consultancy, Boyds. In this article, she provides her expert insights into the key regulatory developments likely to shape the global drug development industry this year.    Implementation of the EU Clinical Trials Regulation  The way clinical trials (CTs)… Read More

#Business & Investment #Exclusive Content #Opinion #Regulatory #Trends & Analysis